Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

ClinicalTrials.gov ID: NCT04265261

Public ClinicalTrials.gov record NCT04265261. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Masked, 48-Week, Parallel-Group, Placebo-Controlled, Proof-of-Concept Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Study identification

NCT ID
NCT04265261
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
139 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • RG7774 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 4, 2020
Primary completion
Jul 18, 2023
Completion
Jul 18, 2023
Last update posted
Sep 24, 2024

2020 – 2023

United States locations

U.S. sites
37
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
Arizona Retina and Vitreous Consultants Phoenix Arizona 85016
Retina Associates Tucson Tucson Arizona 85710
Win Retina Arcadia California 91006
Global Research Management Glendale California 91204
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance California 90502
Retina Consultants of Southern Colorado PC Colorado Springs Colorado 80909
Retina Group of New England Waterford Connecticut 06385
Rand Eye Deerfield Beach Florida 33064
Florida Retina Consultants Lakeland Florida 33805
Florida Eye Associates Melbourne Florida 32901
Medeye Associates Miami Florida 33143
Retina Specialty Institute Pensacola Florida 32503
Retina Vitreous Assoc of FL St. Petersburg Florida 33711
Southeast Retina Center Augusta Georgia 30909
Marietta Eye Clinic Marietta Georgia 30060
Retina Associated Ltd Elmhurst Illinois 60126
University Retina and Macula Associates, PC Oak Forest Illinois 60452
Cumberland Valley Retina PC Hagerstown Maryland 21740
University of Michigan, Kellogg Eye Center Ann Arbor Michigan 48105
Deep Blue Retina PLLC Southaven Mississippi 38671
Sierra Eye Associates Reno Nevada 89502
Envision Ocular, LLC Bloomfield New Jersey 07003
Eye Associates of New Mexico Albuquerque New Mexico 87109
Velocity Clinical Research East Syracuse New York 13057
Ophthalmic Consultants of Long Island Oceanside New York 11572
Charlotte Eye Ear Nose and Throat Associates Charlotte North Carolina 28210
EyeHealth Northwest Portland Oregon 97225
Erie Retinal Surgery Erie Pennsylvania 16507
Charleston Neuroscience Institute Ladson South Carolina 29456
Southeastern Retina Associates Chattanooga Chattanooga Tennessee 37421
Charles Retina Institute Germantown Tennessee 38138
Retina Res Institute of Texas Abilene Texas 79606
Austin Clinical Research LLC Austin Texas 78750
San Antonio Eye Center San Antonio Texas 78215
Retina Consultants of Texas The Woodlands Texas 77384-4167
Retinal Consultants of Houston The Woodlands Texas 77384
Strategic Clinical Research Group, LLC Willow Park Texas 76087

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04265261, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04265261 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →